Open access in medical journals - interview with Richard Smith
Newsletters and Deep Dive digital magazine
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.
Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.
A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
Join us for our popular event to see how your skills and interests could add value to this vital and constantly evolving industry.
Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox